Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Reported Earlier, MediciNova's MN-166 (Ibudilast) ALS Clinical Trial Abstract Accepted For Presentation At 2024 NEALS Annual Meeting

Author: Benzinga Newsdesk | September 04, 2024 03:23am

Posted In: MNOV

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist